GRFS
Grifols, S.A.
NASDAQ · Healthcare · Drug Manufacturers - General · ES
$7.80
−1.02%Institutional positioning
13F filings over the trailing two quarters
New 45Increased 128Reduced 122Sold out 38
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | Increased | 37,816,285 | Aug 14, 2026 |
| BRANDES INVESTMENT PARTNERS, LP | Increased | 36,333,714 | May 15, 2026 |
| CAPITAL WORLD INVESTORS | Unchanged | 22,924,990 | May 13, 2026 |
| Capital World Investors | Reduced | 22,911,656 | Aug 12, 2026 |
| Permian Investment Partners, LP | Increased | 19,740,679 | Aug 14, 2026 |
| PERMIAN INVESTMENT PARTNERS, LP | Increased | 19,354,679 | May 15, 2026 |
| BLACK CREEK INVESTMENT MANAGEMENT INC. | Reduced | 8,386,452 | May 13, 2026 |
| Black Creek Investment Management Inc. | Reduced | 7,682,055 | Aug 12, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 6,550,337 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 5,005,532 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 4,369,934 | Aug 14, 2026 |
| Flat Footed LLC | Increased | 4,349,708 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 4,327,413 | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 3,290,089 | May 18, 2026 |
| UBS GROUP AG | Increased | 3,156,653 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings